title: Lack of in vitro effect of aglepristone on IFN-γ and IL-4 production by resting and mitogen-activated T cells of luteal bitches.
abstract: BACKGROUND
  Aglepristone (RU534) is an antiprogestin used for pregnancy termination, parturition induction and conservative pyometra treatment in bitches. Its molecular structure is similar to mifepristone, an antiprogestin used in human medicine. Mifepristone has been shown to suppress proliferation and cytokine production by T cells, whereas the effect of aglepristone on T cell function remains elusive. The purpose of this project was to investigate the in vitro influence of RU534 on IFN-γ and IL-4 synthesis by peripheral blood T cells isolated from healthy bitches (N = 16) in luteal phase. The peripheral blood mononuclear cells (PBMCs) were incubated with three different dosages of aglepristone, or dimethyl sulfoxide (DMSO), with or without mitogen. The production of cytokines by resting or mitogen-activated T cells was determined by intercellular staining and flow cytometry analysis or ELISA assay, respectively.
  
  
  RESULTS
  Our results showed no statistically significant differences in the percentage of IFN-γ and IL-4-synthesizing CD4+ or CD8+ resting T cells between untreated and aglepristone-treated cells at 24 and 48 hours post treatment. Moreover, mitogen-activated PBMCs treated with RU534 displayed similar concentration of IFN-γ and IL-4 in culture supernatants to those observed in mitogen-activated DMSO-treated PBMCs. Presented results indicate that administration of aglepristone for 48 hours has no influence on IFN-γ and IL-4 synthesis by resting and mitogen-activated T cells isolated from diestral bitches.
  
  
  CONCLUSIONS
  We conclude that antiprogestins may differentially affect T cell function depending on the animal species in which they are applied.
authors.affiliation: Department of Small Animal Diseases with Clinic, Laboratory of Small Animal Reproduction, Warsaw, Poland. piotr_jurka@sggw.pl.
authors.forename: Piotr
authors.initials: P
authors.lastname: Jurka
authors.forename: Lidia
authors.initials: L
authors.lastname: Szulc-Dąbrowska
authors.forename: Joanna
authors.initials: J
authors.lastname: Borkowska
authors.forename: Anna
authors.initials: A
authors.lastname: Winnicka
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D004963:Estrenes / Q000494:pharmacology*; D005260:Female; D005434:Flow Cytometry / Q000662:veterinary; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000096:biosynthesis*; D015847:Interleukin-4 / Q000096:biosynthesis*; D008183:Luteal Phase / Q000502:physiology; D008934:Mitogens / Q000494:pharmacology; D011372:Progestins / Q000037:antagonists & inhibitors*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism
chemical_list: D004963:Estrenes; D008934:Mitogens; D011372:Progestins; C419063:aglepristone; D015847:Interleukin-4; D007371:Interferon-gamma; D004121:Dimethyl Sulfoxide